ABOUT: Good Thursday Morning, Its September 8th, 2011, I’m Sara Bryant with CRWENewswire Stocks In Action. According to reports, PerkinElmer has agreed to buy Caliper Life Sciences Incorporated - symbol CALP - for $10.50 per share or $600 million. This aquisition will help PerkinElmer broaden its reach in molecular imaging and genomic detection technologies. ACE Limited has entered into a definitive agreement to acquire Penn Millers Holding Corporation - symbol PMIC - for $107 million or $20.50 per share in cash. and finally; Marshall Edwards Incorporated - symbol MSHL - has initiated a Phase I clinical trial of the Company’s lead product candidate ME-143 in patients with refractory solid tumors. According to the company, In pre-clinical studies, ME-143 has demonstrated potent activity against a number of tumor cell lines. Thanks for joining me and have a great day! For CRWE Newswire, Stocks In Action, I’m Sara Bryant